In Vivo Evaluation of the Anticancer Activity of the Gemcitabine and Doxorubicin Combined in a Nanoemulsion

CONTEXT: Doxorubicin (DOX) and gemcitabine (GEM) are anticancer drugs that were combined in a nanoemulsion (NE) to reduce their adverse side effects. AIM: To detect the antitumor activity of the combination formulas of GEM and DOX, loaded either in water (GEM+DOX-Sol) or in NEs (GEM–DOX combination/...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkhatib, Mayson H., Alshehri, Wafa S., Abdu, Faiza B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887650/
https://www.ncbi.nlm.nih.gov/pubmed/29657506
http://dx.doi.org/10.4103/jpbs.JPBS_225_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887650/
https://www.ncbi.nlm.nih.gov/pubmed/29657506
http://dx.doi.org/10.4103/jpbs.JPBS_225_17

Ejemplares similares